retatrutide phase 2 trial dose escalation schedule Dosing Guide for Researchers The Retatrutide Dosage Chart

Survodutide (Boehringer Ingelheim, Phase 3 SYNCHRONIZE) and mazdutide (Innovent, approved in China, filed ex-China) both sit in the ~14-18% placebo-adjusted range at their highest-dose arms - comfortably above semaglutide, comfortably below the triples

Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study

No serious drug-related side effects were reported, signaling a strong safety profile so far

17 HamreK.ZhangW.AustgulenM

If you are considering peptide therapy, we are here to help you explore your options and move forward with clarity and confidence